• Disease-free survival (DFS) was measured from the date the complete response was established until the relapse of leukemia or death from any cause, with observations censored for patients last known to be alive without report of relapse. (bloodjournal.org)
  • Apperley J (2007) Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia. (springer.com)
  • Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong A, Pattacini L, Goldman JM, Melo JV (2005) BCR-ABL expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia. (springer.com)
  • When chronic myeloid leukemia is difficult to control with Gleevec® (imatinib) or other therapies, the white blood count begins to increase. (cancerconnect.com)
  • Children with AML who have a white blood cell count (WBC) greater than 100,000 per cubic milliliter, secondary AML, and leukemic cells with a monosomy 7 karyotype have low remission induction rates, whereas children with leukemia cell chromosomal abnormalities t(8;21) and inv 16 have a high likelihood of achieving remission. (meds.com)
  • Other chemotherapy agents, specifically epipodophyllotoxins and anthracyclines, have also been associated with treatment-related leukemias, which are often associated with specific chromosomal abnormalities in the leukemic cells. (wikipedia.org)
  • As Virchow was uncertain of the cause of the white blood cell excess, he used the purely descriptive term 'leukemia' (Greek: 'white blood') to refer to the condition. (news-medical.net)